Kinsale Capital Group Q1 2026 Earnings Strong EPS Beat Belied by Modest Share Decline Fate Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Pipeline Development ALT Q1 2026 Earnings Narrowed Loss and EPS Beat Signal Progress in Metabolic Pipeline NUVB Q1 2026 Earnings Narrow EPS Beat Reflects Continued Pipeline Progress Pyxis Oncology Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction SoFi Q1 2026 Earnings EPS Falls Just Shy of Estimates Stock Declines